カテゴリー： QYResearch, 世界

世界の遺伝子工学薬品市場 2019年

【英語タイトル】Global Genetic Engineering Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08414）・商品コード：DATA909X08414
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、遺伝子工学薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、組換えヒトエリスロポエチン、組換えヒトインターフェロン、組換えヒト成長ホルモン、組換えヒトインスリンに、用途別には、＜30歳、30歳〜60歳、＞ 60歳にセグメント区分し、遺伝子工学薬品の世界市場を分析しました。


・エグゼクティブ・サマリー
・遺伝子工学薬品の世界市場概要
・遺伝子工学薬品の製造コスト構成分析
・遺伝子工学薬品の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・遺伝子工学薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・遺伝子工学薬品のセグメント分析（種類別）
（モノクローナル抗体、組換えヒトエリスロポエチン、組換えヒトインターフェロン、組換えヒト成長ホルモン、組換えヒトインスリン）
・遺伝子工学薬品のセグメント分析（用途別）
（＜30歳、30歳〜60歳、＞ 60歳）
・遺伝子工学薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Shanghai Lansheng Guojian Pharmaceutical、Biotech Pharmaceutical、Anhui Anke Biotechnology、GeneScience Pharmaceuticals、Beijing SL Pharmaceutical、Jiangsu Sihuan Bioengineering、Shenzhen Neptunus Interlong Bio-Technique、3SBio、Tonghua Dongbao Pharmaceutical、）
・遺伝子工学薬品の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Genetic Engineering Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Genetic Engineering Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Genetic Engineering Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Genetic Engineering Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Genetic Engineering Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin

Segment by Application
＜30 Years Old
30 Years Old-60 Years Old
＞60 Years Old

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Genetic Engineering Drug
1.1 Definition of Genetic Engineering Drug
1.2 Genetic Engineering Drug Segment by Type
1.2.1 Global Genetic Engineering Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Genetic Engineering Drug Segment by Applications
1.3.1 Global Genetic Engineering Drug Consumption Comparison by Applications (2014-2025)
1.3.2 ＜30 Years Old
1.3.3 30 Years Old-60 Years Old
1.3.4 ＞60 Years Old
1.4 Global Genetic Engineering Drug Overall Market
1.4.1 Global Genetic Engineering Drug Revenue (2014-2025)
1.4.2 Global Genetic Engineering Drug Production (2014-2025)
1.4.3 North America Genetic Engineering Drug Status and Prospect (2014-2025)
1.4.4 Europe Genetic Engineering Drug Status and Prospect (2014-2025)
1.4.5 China Genetic Engineering Drug Status and Prospect (2014-2025)
1.4.6 Japan Genetic Engineering Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Genetic Engineering Drug Status and Prospect (2014-2025)
1.4.8 India Genetic Engineering Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Genetic Engineering Drug
2.3 Manufacturing Process Analysis of Genetic Engineering Drug
2.4 Industry Chain Structure of Genetic Engineering Drug

3 Development and Manufacturing Plants Analysis of Genetic Engineering Drug
3.1 Capacity and Commercial Production Date
3.2 Global Genetic Engineering Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Genetic Engineering Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Genetic Engineering Drug Production and Capacity Analysis
4.2 Genetic Engineering Drug Revenue Analysis
4.3 Genetic Engineering Drug Price Analysis
4.4 Market Concentration Degree

5 Genetic Engineering Drug Regional Market Analysis
5.1 Genetic Engineering Drug Production by Regions
5.1.1 Global Genetic Engineering Drug Production by Regions
5.1.2 Global Genetic Engineering Drug Revenue by Regions
5.2 Genetic Engineering Drug Consumption by Regions
5.3 North America Genetic Engineering Drug Market Analysis
5.3.1 North America Genetic Engineering Drug Production
5.3.2 North America Genetic Engineering Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Genetic Engineering Drug Import and Export
5.4 Europe Genetic Engineering Drug Market Analysis
5.4.1 Europe Genetic Engineering Drug Production
5.4.2 Europe Genetic Engineering Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Genetic Engineering Drug Import and Export
5.5 China Genetic Engineering Drug Market Analysis
5.5.1 China Genetic Engineering Drug Production
5.5.2 China Genetic Engineering Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Genetic Engineering Drug Import and Export
5.6 Japan Genetic Engineering Drug Market Analysis
5.6.1 Japan Genetic Engineering Drug Production
5.6.2 Japan Genetic Engineering Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Genetic Engineering Drug Import and Export
5.7 Southeast Asia Genetic Engineering Drug Market Analysis
5.7.1 Southeast Asia Genetic Engineering Drug Production
5.7.2 Southeast Asia Genetic Engineering Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Genetic Engineering Drug Import and Export
5.8 India Genetic Engineering Drug Market Analysis
5.8.1 India Genetic Engineering Drug Production
5.8.2 India Genetic Engineering Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Genetic Engineering Drug Import and Export

6 Genetic Engineering Drug Segment Market Analysis (by Type)
6.1 Global Genetic Engineering Drug Production by Type
6.2 Global Genetic Engineering Drug Revenue by Type
6.3 Genetic Engineering Drug Price by Type

7 Genetic Engineering Drug Segment Market Analysis (by Application)
7.1 Global Genetic Engineering Drug Consumption by Application
7.2 Global Genetic Engineering Drug Consumption Market Share by Application (2014-2019)

8 Genetic Engineering Drug Major Manufacturers Analysis
8.1 Shanghai Lansheng Guojian Pharmaceutical
8.1.1 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
8.1.2 Shanghai Lansheng Guojian Pharmaceutical Product Introduction, Application and Specification
8.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biotech Pharmaceutical
8.2.1 Biotech Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
8.2.2 Biotech Pharmaceutical Product Introduction, Application and Specification
8.2.3 Biotech Pharmaceutical Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Anhui Anke Biotechnology
8.3.1 Anhui Anke Biotechnology Genetic Engineering Drug Production Sites and Area Served
8.3.2 Anhui Anke Biotechnology Product Introduction, Application and Specification
8.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GeneScience Pharmaceuticals
8.4.1 GeneScience Pharmaceuticals Genetic Engineering Drug Production Sites and Area Served
8.4.2 GeneScience Pharmaceuticals Product Introduction, Application and Specification
8.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Beijing SL Pharmaceutical
8.5.1 Beijing SL Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
8.5.2 Beijing SL Pharmaceutical Product Introduction, Application and Specification
8.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Jiangsu Sihuan Bioengineering
8.6.1 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production Sites and Area Served
8.6.2 Jiangsu Sihuan Bioengineering Product Introduction, Application and Specification
8.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Shenzhen Neptunus Interlong Bio-Technique
8.7.1 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production Sites and Area Served
8.7.2 Shenzhen Neptunus Interlong Bio-Technique Product Introduction, Application and Specification
8.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 3SBio
8.8.1 3SBio Genetic Engineering Drug Production Sites and Area Served
8.8.2 3SBio Product Introduction, Application and Specification
8.8.3 3SBio Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Tonghua Dongbao Pharmaceutical
8.9.1 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
8.9.2 Tonghua Dongbao Pharmaceutical Product Introduction, Application and Specification
8.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Genetic Engineering Drug Market
9.1 Global Genetic Engineering Drug Market Trend Analysis
9.1.1 Global Genetic Engineering Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Genetic Engineering Drug Regional Market Trend
9.2.1 North America Genetic Engineering Drug Forecast 2019-2025
9.2.2 Europe Genetic Engineering Drug Forecast 2019-2025
9.2.3 China Genetic Engineering Drug Forecast 2019-2025
9.2.4 Japan Genetic Engineering Drug Forecast 2019-2025
9.2.5 Southeast Asia Genetic Engineering Drug Forecast 2019-2025
9.2.6 India Genetic Engineering Drug Forecast 2019-2025
9.3 Genetic Engineering Drug Market Trend (Product Type)
9.4 Genetic Engineering Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Genetic Engineering Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Genetic Engineering Drug
Table Global Genetic Engineering Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Genetic Engineering Drug Production Market Share by Types in 2018
Figure Monoclonal Antibody Product Picture
Figure Recombinant Human Erythropoietin Product Picture
Figure Recombinant Human Interferon Product Picture
Figure Recombinant Human Growth Hormone Product Picture
Figure Recombinant Human Insulin Product Picture
Table Global Genetic Engineering Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Genetic Engineering Drug Consumption Market Share by Applications in 2018
Figure ＜30 Years Old
Figure 30 Years Old-60 Years Old
Figure ＞60 Years Old
Figure Global Genetic Engineering Drug Revenue (Million USD) (2014-2025)
Figure Global Genetic Engineering Drug Production (K Units) (2014-2025)
Figure North America Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Figure Europe Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Figure China Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Figure Japan Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Figure India Genetic Engineering Drug Market Size (Million USD) (2014-2025)
Table Genetic Engineering Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2018
Figure Manufacturing Process Analysis of Genetic Engineering Drug
Figure Industry Chain Structure of Genetic Engineering Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Genetic Engineering Drug Manufacturing Plants Distribution
Table Genetic Engineering Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Genetic Engineering Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Genetic Engineering Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Genetic Engineering Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Genetic Engineering Drug Production Share by Manufacturers in 2018
Table Genetic Engineering Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Genetic Engineering Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Genetic Engineering Drug Revenue Share by Manufacturers in 2018
Table Genetic Engineering Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Genetic Engineering Drug Production by Regions 2014-2019 (K Units)
Table Global Genetic Engineering Drug Production Market Share by Regions 2014-2019
Figure Global Genetic Engineering Drug Production Market Share by Regions in 2018
Table Global Genetic Engineering Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Genetic Engineering Drug Revenue Market Share by Regions 2014-2019
Figure Global Genetic Engineering Drug Revenue Market Share by Regions in 2018
Table Global Genetic Engineering Drug Consumption by Regions 2014-2019 (K Units)
Table Global Genetic Engineering Drug Consumption Market Share by Regions 2014-2019
Figure North America Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure Europe Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure China Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure China Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure Japan Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure India Genetic Engineering Drug Production Growth Rate 2014-2019 (K Units)
Figure India Genetic Engineering Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Genetic Engineering Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Genetic Engineering Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Genetic Engineering Drug Market Share by Application (2014-2019)
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Introduction, Application and Specification
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production Market Share (2014-2019)
Figure Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Main Business and Markets Served
Table Biotech Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
Table Biotech Pharmaceutical Genetic Engineering Drug Product Introduction, Application and Specification
Table Biotech Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biotech Pharmaceutical Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Biotech Pharmaceutical Genetic Engineering Drug Production Market Share (2014-2019)
Figure Biotech Pharmaceutical Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Biotech Pharmaceutical Genetic Engineering Drug Main Business and Markets Served
Table Anhui Anke Biotechnology Genetic Engineering Drug Production Sites and Area Served
Table Anhui Anke Biotechnology Genetic Engineering Drug Product Introduction, Application and Specification
Table Anhui Anke Biotechnology Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Anhui Anke Biotechnology Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Anhui Anke Biotechnology Genetic Engineering Drug Production Market Share (2014-2019)
Figure Anhui Anke Biotechnology Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Anhui Anke Biotechnology Genetic Engineering Drug Main Business and Markets Served
Table GeneScience Pharmaceuticals Genetic Engineering Drug Production Sites and Area Served
Table GeneScience Pharmaceuticals Genetic Engineering Drug Product Introduction, Application and Specification
Table GeneScience Pharmaceuticals Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GeneScience Pharmaceuticals Genetic Engineering Drug Production Growth Rate (2014-2019)
Table GeneScience Pharmaceuticals Genetic Engineering Drug Production Market Share (2014-2019)
Figure GeneScience Pharmaceuticals Genetic Engineering Drug Revenue Market Share (2014-2019)
Table GeneScience Pharmaceuticals Genetic Engineering Drug Main Business and Markets Served
Table Beijing SL Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
Table Beijing SL Pharmaceutical Genetic Engineering Drug Product Introduction, Application and Specification
Table Beijing SL Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Beijing SL Pharmaceutical Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Beijing SL Pharmaceutical Genetic Engineering Drug Production Market Share (2014-2019)
Figure Beijing SL Pharmaceutical Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Beijing SL Pharmaceutical Genetic Engineering Drug Main Business and Markets Served
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production Sites and Area Served
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Introduction, Application and Specification
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production Market Share (2014-2019)
Figure Jiangsu Sihuan Bioengineering Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Main Business and Markets Served
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production Sites and Area Served
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Introduction, Application and Specification
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production Market Share (2014-2019)
Figure Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Main Business and Markets Served
Table 3SBio Genetic Engineering Drug Production Sites and Area Served
Table 3SBio Genetic Engineering Drug Product Introduction, Application and Specification
Table 3SBio Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table 3SBio Genetic Engineering Drug Production Growth Rate (2014-2019)
Table 3SBio Genetic Engineering Drug Production Market Share (2014-2019)
Figure 3SBio Genetic Engineering Drug Revenue Market Share (2014-2019)
Table 3SBio Genetic Engineering Drug Main Business and Markets Served
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production Sites and Area Served
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Introduction, Application and Specification
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production Growth Rate (2014-2019)
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production Market Share (2014-2019)
Figure Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Revenue Market Share (2014-2019)
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Main Business and Markets Served
Figure Global Genetic Engineering Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Genetic Engineering Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Genetic Engineering Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Genetic Engineering Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Genetic Engineering Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Genetic Engineering Drug by Type (2019-2025)
Table Global Consumption (K Units) of Genetic Engineering Drug by Application (2019-2025)
Table Genetic Engineering Drug Distributors List
Table Genetic Engineering Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Shanghai Lansheng Guojian Pharmaceutical、Biotech Pharmaceutical、Anhui Anke Biotechnology、GeneScience Pharmaceuticals、Beijing SL Pharmaceutical、Jiangsu Sihuan Bioengineering、Shenzhen Neptunus Interlong Bio-Technique、3SBio、Tonghua Dongbao Pharmaceutical、

★調査レポート[世界の遺伝子工学薬品市場 2019年] (コード：DATA909X08414)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の遺伝子工学薬品市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の遺伝子解析機器市場 2019年
    DATA909X08413 / QYResearch / 2019年11月15日 / ※本調査レポートは、遺伝子解析機器の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、DNAマイクロアレイ、PCR、次世代シーケンシング、遺伝子発現連続分析、ノーザンブロット法に、用途別には、診断センター、創薬、研究開発、その他にセグメント区分し、遺伝子解析機器の世界市場を分析しました。 ・エグゼクティブ・サマリー ・遺伝子解析機器の世界市場概要 ・遺伝子解析機器の製造コスト構成分析 ・遺伝子解析機器の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・遺伝子解析機器の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・遺伝子解析機器のセグメント分析（種類別） （DNAマイクロアレイ、PCR、次世代シーケンシング、遺伝子発現連続分析、ノーザンブロット法）...The global Genetic Analyzer market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Genetic Analyzer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Genetic Analyzer market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Genetic Analyzer in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Genetic Analyzer manufacturing...
  • 遺伝性疾患用遺伝子治療の世界市場：規模・現状・予測2019-2025
    DATA909X18502 / QYResearch / 2019年11月25日 / ※当調査レポートでは、遺伝性疾患用遺伝子治療の世界市場について調査・分析し、遺伝性疾患用遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他）、用途別（病院、診療所、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の遺伝性疾患用遺伝子治療市場動向 ・主要企業別マーケットシェア ・遺伝性疾患用遺伝子治療の種類別市場規模2014-2019 （眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他） ・遺伝性疾患用遺伝子治療の用途別市場規模2014-2019 （病院、診療所、研究所、その他） ・遺伝性疾患用遺伝子治療の北米市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders. In 2018, the global Gene Therapy for Inherited Genetic Disorders market size was xx million US$ and it is...
  • 世界の動物遺伝子産物市場 2019年
    DATA909X03588 / QYResearch / 2019年11月15日 / ※本調査レポートは、動物遺伝子産物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、精液、胚、その他に、用途別には、家禽、豚、牛、犬、その他にセグメント区分し、動物遺伝子産物の世界市場を分析しました。 ・エグゼクティブ・サマリー ・動物遺伝子産物の世界市場概要 ・動物遺伝子産物の製造コスト構成分析 ・動物遺伝子産物の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・動物遺伝子産物の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・動物遺伝子産物のセグメント分析（種類別） （精液、胚、その他）...The global Animal Genetic Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Genetic Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Animal Genetic Products market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Animal Genetic Products in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の予測遺伝子検査及び消費者/ウェルネスゲノミクス市場 2019年
    DATA909X13668 / QYResearch / 2019年11月20日 / ※本調査レポートは、予測遺伝子検査及び消費者/ウェルネスゲノミクスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、予測試験、消費者ゲノミクス、ウェルネスゲノミクスに、用途別には、乳がん、卵巣がん、心血管スクリーニング、糖尿病のスクリーニングとモニタリング、結腸がん、その他にセグメント区分し、予測遺伝子検査及び消費者/ウェルネスゲノミクスの世界市場を分析しました。 ・エグゼクティブ・サマリー ・予測遺伝子検査及び消費者/ウェルネスゲノミクスの世界市場概要 ・予測遺伝子検査及び消費者/ウェルネスゲノミクスの製造コスト構成分析 ・予測遺伝子検査及び消費者/ウェルネスゲノミクスの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・予測遺伝子検査及び消費者/ウェルネスゲノミクスの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・予測遺伝子検査及び消費者/ウェルネスゲノミクスのセグメント分析（種類別） （予測試験、消費者ゲノミクス、ウェルネスゲノミクス）...The global Predictive Genetic Testing And Consumer/Wellness Genomics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Predictive Genetic Testing And Consumer/Wellness Genomics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Predictive Genetic Testing And Consumer/Wellness Genomics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Predictive Genetic Testing And Consumer/Wellness Genomics in North America, Europe, China,...
  • 世界の抗潰瘍薬市場 2019年
    DATA909X03682 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗潰瘍薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、重炭酸ナトリウム、3ケイ酸マグネシウム、その他に、用途別には、病院、医療センター、その他にセグメント区分し、抗潰瘍薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗潰瘍薬の世界市場概要 ・抗潰瘍薬の製造コスト構成分析 ・抗潰瘍薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗潰瘍薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗潰瘍薬のセグメント分析（種類別） （重炭酸ナトリウム、3ケイ酸マグネシウム、その他）...The global Anti-ulcer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti-ulcer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-ulcer Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anti-ulcer Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Anti-ulcer Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆